Bicocca Open Archive

Logo unimib boa
QUARTI TREVANO, FOSCA ANNA LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.893
EU - Europa 6.096
AS - Asia 3.932
SA - Sud America 226
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 21.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.724
SG - Singapore 1.435
RU - Federazione Russa 1.301
HK - Hong Kong 1.229
DE - Germania 1.045
IT - Italia 922
SE - Svezia 890
CN - Cina 784
IE - Irlanda 669
UA - Ucraina 441
GB - Regno Unito 257
BR - Brasile 196
CA - Canada 147
FI - Finlandia 145
AT - Austria 126
VN - Vietnam 113
FR - Francia 94
KR - Corea 92
IN - India 69
ID - Indonesia 64
NL - Olanda 48
DK - Danimarca 42
TR - Turchia 31
JP - Giappone 30
CZ - Repubblica Ceca 25
BE - Belgio 24
ZA - Sudafrica 17
MX - Messico 14
IR - Iran 12
PL - Polonia 9
AU - Australia 8
LT - Lituania 8
PH - Filippine 8
BD - Bangladesh 7
IQ - Iraq 7
LK - Sri Lanka 7
MK - Macedonia 7
RO - Romania 7
UZ - Uzbekistan 7
AR - Argentina 6
EC - Ecuador 6
VE - Venezuela 6
CL - Cile 5
ES - Italia 5
KE - Kenya 5
PE - Perù 5
EU - Europa 4
HU - Ungheria 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EE - Estonia 3
JO - Giordania 3
MU - Mauritius 3
MY - Malesia 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
GD - Grenada 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
MG - Madagascar 2
NG - Nigeria 2
NO - Norvegia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
UG - Uganda 1
Totale 21.198
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.182
Hong Kong 1.221
Singapore 1.005
Fairfield 986
Woodbridge 936
Houston 694
Frankfurt am Main 665
Dublin 633
Chandler 572
Ashburn 509
Wilmington 505
Jacksonville 466
Seattle 360
Dearborn 317
Cambridge 307
New York 275
Milan 265
Princeton 246
Santa Clara 239
Moscow 149
Lawrence 121
Altamura 120
Beijing 114
Nanjing 113
Vienna 105
Shanghai 98
Seoul 86
Lachine 73
Hefei 71
San Diego 67
Munich 55
Boardman 54
Jakarta 51
Lissone 50
Dong Ket 44
Guangzhou 44
Helsinki 43
Andover 42
Nanchang 38
Council Bluffs 37
Hebei 31
London 30
Los Angeles 30
Nuremberg 28
Toronto 27
Changsha 25
Fremont 25
Tianjin 25
Falls Church 24
Rome 24
Monza 22
Ningbo 22
Shenyang 22
Brussels 21
Jiaxing 21
Brno 20
Jinan 20
São Paulo 20
Cinisello Balsamo 18
Kunming 18
Ottawa 18
Turku 17
Mountain View 16
Hangzhou 15
Norwalk 15
San Mateo 15
The Dalles 15
Huizen 14
Auburn Hills 13
Dallas 13
Nürnberg 13
Sacramento 13
San Francisco 13
Ho Chi Minh City 12
Zhengzhou 12
Chicago 11
Düsseldorf 11
Brooklyn 10
Lappeenranta 10
Philadelphia 10
Hanoi 9
Mumbai 9
Padova 9
Rio de Janeiro 9
Brasília 8
Monmouth Junction 8
Pune 8
Tokyo 8
Vimercate 8
Amsterdam 7
Edmonton 7
Groningen 7
Leawood 7
Phoenix 7
Busto Arsizio 6
Colombo 6
Detroit 6
Esslingen am Neckar 6
Fuzhou 6
Kiev 6
Totale 14.844
Salva come PNG Salva come JPEG
Nome #
Heart rate as a sympathetic marker during acute adrenergic challenge 320
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 298
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 265
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 254
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 218
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 212
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 211
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 209
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 208
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 206
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 204
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 200
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 200
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 197
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 196
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 196
Neurogenic abnormalities in masked hypertension 194
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 193
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 192
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 190
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 189
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 189
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 188
Threshold and Target for Blood Pressure Lowering in the Elderly 188
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 186
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 184
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 184
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 181
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 181
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 180
Incident Left Ventricular Hypertrophy in Masked Hypertension 180
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 177
Iron overload exerts sympathoexcitatory effects in men with essential hypertension: microneurogtaphic evidence 177
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 176
Hypertension, antihypertensive treatment and stroke prevention 174
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 173
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 173
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 173
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 171
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 170
Diurnal blood pressure variation and sympathetic activity 170
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 169
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 168
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 168
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 168
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 167
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 164
Baroreflex function in hypertension: consequences for antihypertensive therapy 163
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 163
Should white-coat hypertension in diabetes be treated? Pro 159
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 158
HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs 158
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea 156
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome 155
Early sympathetic activation in the initial clinical stages of chronic renal failure 153
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 153
Blood pressure control and therapeutic modulation of the adrenergic overdrive 152
Blood pressure control in resistant hypertension: new therapeutic options 152
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 151
The "J curve" problem revisited: old and new findings 149
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study 149
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 148
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 148
Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population 147
Sympathetic activation in congestive heart failure: an updated overview 147
Left ventricular hypertrophy in isolated and dual masked hypertension 145
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 143
The 'neuroadrenergic hypothesis' in hypertension: current evidence 143
Salt intake and sympathetic activity - Response 143
Early sympathetic activation in mild renal failure 141
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 141
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis 140
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 139
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 139
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 138
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 136
The importance of pulse pressure on cardiovascular risk and total mortality in the general population: Is sex relevant? 136
Blood pressure lowering effects of Rimonabant in obesità-related hypertension 135
Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers 135
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome 133
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 133
Long-term changes in left ventricular mass echocardiographic findings from a general population 132
Blood pressure control and antihypertensive treatment 130
Essential hypertension and the sympathetic nervous system 130
Long-term risk of sustained hypertension in white-coat or masked hypertension 129
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 129
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial 128
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 127
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 124
Short- and Long-Term Reproducibility of Nighttime Blood Pressure Phenotypes and Nocturnal Blood Pressure Reduction 124
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 123
Left ventricular mass and incident out-of-office hypertension in a general population 123
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 121
Uric acid and risk of new-onsetmetabolic syndrome, impaired fasting glucose and diabetesmellitus in a general Italian population: data from the Pressioni ArterioseMonitorate E Loro Associazioni study 119
The PAMELA research project: a 25-year long journey 119
Adverse prognostic value of persistent office blood pressure elevation in White coat Hypertension 118
Heart rate as a predictor of cardiovascular risk 117
Long QT interval and malignant ventricular arrhythmia during treatment with cisapride. Report of a clinical case 114
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 112
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe 110
Totale 16.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 0 0 0 0 0 0 0 0 62
2020/20212.492 155 147 209 259 175 221 220 239 186 293 140 248
2021/20222.063 165 171 263 201 177 162 110 83 110 128 195 298
2022/20232.814 320 813 274 271 165 453 48 157 159 20 89 45
2023/20242.231 56 56 112 120 298 501 387 74 252 67 51 257
2024/20255.935 321 721 250 268 518 185 299 278 607 979 723 786
Totale 21.827